Back
Zealand Pharma AS Quote, Financials, Valuation and Earnings
Sponsored
ZLDPF
Sponsored
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
49
ZLDPF
Zealand Pharma AS
Last Price:
118.11
Seasonality Move:
5.91%
7 Day Trial
ALL ACCESS PASS
$
7
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More HereZealand Pharma AS Price Quote
$118.11
-2.07 (-1.72%)
(Updated: November 13, 2024 at 9:50 AM ET)
Zealand Pharma AS Key Stats
Sell
49
Zealand Pharma AS (ZLDPF)
is a Sell
Day range:
$118.89 - $121.00
52-week range:
$41.66 - $141.74
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
684.02
P/B ratio:
6.38%
Volume:
1.2K
Avg. volume:
1.2K
1-year change:
197.48%
Market cap:
$8.5B
Revenue:
$49.8M
EPS:
$-2.43
How Much Does Zealand Pharma AS Make?
-
How Much Are Zealand Pharma AS's Sales Annually?
ZLDPF Revenues are $49.8M -
How Much Profit Does Zealand Pharma AS's Make A Year?
ZLDPF net income is -$102.2M
Is Zealand Pharma AS Growing As A Company?
-
What Is Zealand Pharma AS's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.98% -
What Is Zealand Pharma AS's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Zealand Pharma AS Stock Price Performance
-
Did Zealand Pharma AS Stock Go Up Last Month?
Zealand Pharma AS share price went up by 5.09% last month -
Did ZLDPF's Share Price Rise Over The Last Year?
ZLDPF share price rose by 197.48% over the past 1 year
What Is Zealand Pharma AS 52-Week High & Low?
-
What Is Zealand Pharma AS’s 52-Week High Share Price?
Zealand Pharma AS has traded as high as $141.74 over the past 52 weeks -
What Is Zealand Pharma AS’s 52-Week Low Share Price?
Zealand Pharma AS has traded as low as $41.66 over the past 52 weeks
Zealand Pharma AS Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Zealand Pharma AS?
-
How Much Debt Does Zealand Pharma AS Have?
Total long term debt quarterly is $42.1M -
How Much Cash Does Zealand Pharma AS Have?
Cash and short term investments quarterly total is $1.3B -
What Is Zealand Pharma AS’s Book Value Per Share?
Book value per share is 18.83
Is Zealand Pharma AS Cash Flow Positive?
-
What Is ZLDPF Cash Flow From Operations?
Cash flow from operations (TTM) is -$101.5M -
What Is Zealand Pharma AS’s Cash Flow From Financing?
Cash flow from financing (TTM) is $1.2B -
What Is Zealand Pharma AS’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$1.1B
Zealand Pharma AS Return On Invested Capital
-
Is Management Doing A Good Job?
ZLDPF return on invested capital is -20.65% -
What Is Zealand Pharma AS Return On Assets?
ROA measures how assets are converting to revenues and is -19.03% -
What Is ZLDPF Return On Equity?
ROE is a measure of profitability and is -21.35%
Zealand Pharma AS Earnings Date & Stock Price
-
What Is Zealand Pharma AS's Stock Price Today?
A single share of ZLDPF can be purchased today for 120.18 -
What Is Zealand Pharma AS’s Stock Symbol?
Zealand Pharma AS trades on the otcm under the ticker symbol: ZLDPF -
When Is Zealand Pharma AS’s Next Earnings Date?
The next quarterly earnings date for Zealand Pharma AS is scheduled on February 20, 2025 -
When Is ZLDPF's next ex-dividend date?
Zealand Pharma AS's next ex-dividend date is November 13, 2024 -
How To Buy Zealand Pharma AS Stock?
You can buy Zealand Pharma AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Zealand Pharma AS Competitors
-
Who Are Zealand Pharma AS's Competitors?
Below is a list of companies who compete with Zealand Pharma AS or are related in some way:
Zealand Pharma AS Dividend Yield
-
What Is ZLDPF Dividend Yield?
Zealand Pharma AS’s dividend yield currently is 0% -
What Is Zealand Pharma AS’s Payout Ratio?
Zealand Pharma AS’s payout ratio is 0% -
When Did Zealand Pharma AS Last Pay A Dividend?
The latest dividend pay date is November 13, 2024 -
What Is Zealand Pharma AS’s Dividend Per Share?
Zealand Pharma AS pays a dividend of $0.00 per share
Zealand Pharma AS Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 0% |
Revenue: | -98.49% | -91.85% |
Analyst Recommendations
Buy Recommendations: | 1 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 22.50 |
Downside from Last Price: | -81.28% |